Drug
Rifaximin clinical trials
Keep track of what changes. Save the Rifaximin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Other names
Studies by the year they started
149 studies that test it; most in 2013 (15)
| Year | Studies |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 6 |
| 2006 | 2 |
| 2007 | 8 |
| 2008 | 5 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 8 |
| 2013 | 15 |
| 2014 | 7 |
| 2015 | 10 |
| 2016 | 10 |
| 2017 | 6 |
| 2018 | 10 |
| 2019 | 11 |
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 8 |
| 2025 | 5 |
| 2026 | 7 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 19 · Other 130
Bausch Health Americas, Inc. (15) · Institute of Liver and Biliary Sciences, India (6) · Mayo Clinic (5) · Shanghai Changzheng Hospital (4) · Shanghai Zhongshan Hospital (4) · University of Michigan (3) · Emory University (3) · Cedars-Sinai Medical Center (3)
Often tested with
Tested in the same studies.
Lactulose (11) · Probiotic (2) · Ciprofloxacin (2) · Simvastatin (2) · Glipizide (1) · Neomycin (1) · Ornithylaspartate (1) · Bromocriptine (1)
Studies
Open first, then newest update. How each study uses Rifaximin is read from its arms, and is right about nine times in ten.
Testing it · 149
- Rifaximin for the Secondary Prevention of Recurrent PouchitisRecruitingPhase 4University of North Carolina, Chapel HillNCT06312683Written as Rifaximin 550 MG Oral Tablet [XIFAXAN]
- SIMBA in Irritable Bowel Syndrome (IBS)Not yet recruitingPhase 1University of CalgaryNCT07882953Written as Rifaximin (drug)
- Rifaximin Versus No Intervention for the Treatment of IgG/IgA (Non-IgM) Monoclonal Gammopathy of Undetermined SignificanceRecruitingPhase 2Fred Hutchinson Cancer CenterNCT07209371Written as Rifaximin
- Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute DiarrheaRecruitingPhase 4Bausch Health Americas, Inc.NCT07285785Written as Rifaximin 200 mg Tablet
- Efficacy of Rifaximin With NAC in IBS-DRecruitingPhase 2Mark Pimentel, MDNCT06727422Written as rifaximin 66mg + N-acetylcysteine 560mg three times daily
- Rifaximin Treatment in Bloating Predominant Functional Bowel DisordersNot yet recruitingPhase 3Mahidol UniversityNCT07522255Written as Rifaximin (drug)
- Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on TicagrelorNot yet recruitingPhase 4Collegium Medicum w BydgoszczyNCT07203846Written as Rifaximin
- Efficacy and Safety of Rifaximin in Treating MAFLDRecruitingEarly Phase 1Shanghai Changzheng HospitalNCT07185932Written as Rifaximin (Xifaxan)
- Gut Decolonisation With Neomycin/Metronidazole or Rifaximin Before Colon SurgeryNot yet recruitingPhase 4Universität LuzernNCT07180615Written as Rifaximin (Xifaxan)
- Effect of Rifaximin on Gut Bacterial Flora Post Stem Cell Transplant in Patients With Acute LeukemiaRecruitingPhase 2Tata Memorial CentreNCT06058572Written as Rifaximin 200Mg Tab
- BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HERecruitingPhase 4Post Graduate Institute of Medical Education and Research, ChandigarhNCT06538077Written as Rifaximin 550 MG
- Single Dose Antibiotic Treatment of Acute Watery Diarrhea, Rifaximin Versus Azithromycin, With Loperamide AdjunctRecruitingPhase 4Henry M. Jackson Foundation for the Advancement of Military MedicineNCT05677282Written as Rifaximin 550 MG
- Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating.RecruitingNot applicableXiuli ZuoNCT06772064Written as Rifaximin (drug)
- Effect of Perioperative Oral Rifaximin on Early Graft Dysfunction in Adult Living Donor Liver TransplantRecruitingNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT06743464Written as Rifaximin 550 MG
- Goal Directed Ammonia Lowering Therapy in Hyperammonemic ACLF Patients With no Overt HE to Reduce Major Adverse Liver Related Outcomes (GOAL Trial)Not yet recruitingNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT06808009Written as Rifaximin
- Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and LactuloseRecruitingPhase 4Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT04073290Written as Rifaximin 550 milligram Oral Tablet [XIFAXAN]
- Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer PatientsNot yet recruitingPhase 1/2Mansoura UniversityNCT06783153Written as Rifaximin 550 MG
- Effects of Rifaximin on Gut Microbiota and EmotionRecruitingPhase 2/3Universitaire Ziekenhuizen KU LeuvenNCT05587036Written as Rifaximin
- Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection FractionRecruitingNot applicableI.M. Sechenov First Moscow State Medical UniversityNCT06652087Written as Rifaximin
- Study of Clinical Features and Efficacy of Small Intestinal Bacterial Overgrowth in Patients With Abdominal DistensionNot yet recruitingPhase 1/2Peking Union Medical College HospitalNCT06518850Written as Rifaximin
See all 149 studies that test Rifaximin →
Given in every arm · 7 — Rifaximin is usual care beside what is tested
- Effect of Multispecies Probiotic Supplementation on the Efficacy of Rifaximin α Therapy in Patients With Small Intestinal Bacterial Overgrowth (SIBO): a Randomized Placebo-controlled TrialNot yet recruitingPhase 4Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i AdministracjiNCT07426705Written as Rifaximin (drug)
- Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)RecruitingNot applicableGeneral Hospital of Shenyang Military RegionNCT06483737Written as Rifaximin
- Efficacy and Safety of Nifuroxazide in the Treatment of Hepatic Encephalopathy in Egyptian Patients With Liver CirrhosisCompletedPhase 3Cairo UniversityNCT05754996Written as Rifaximin 550Mg Tab
- To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With DiarrheaCompletedPhase 4Bahria UniversityNCT05867550Written as Rifaximin 550 MG
- Efficacy and Safety of Rifaximin With NAC in IBS-DCompletedPhase 1/2Cedars-Sinai Medical CenterNCT04557215Written as Rifaximin
- Fecal Microbial Transplant in Pediatric Crohn's DiseaseTerminatedPhase 1/2Seattle Children's HospitalNCT02272868Written as rifaximin+omeprazole+miralax
- The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic EncephalopathyCompletedPhase 4Bausch Health Americas, Inc.NCT01842581Written as Rifaximin
As the comparator · 12 — what is tested is compared with Rifaximin
- Comparison of the Efficacy of Saccharomyces Boulardii and Rifaximin in the Treatment of Small Intestinal Bacterial OvergrowthNot yet recruitingPhase 4Shandong UniversityNCT07815548Written as Rifaximin (Xifaxan)
- Feasibility of a New Diagnostic Device to Assess Small Intestinal Dysbiosis in Routine Clinical Setting.RecruitingNot applicableAtmo Biosciences Pty LtdNCT04910815Written as Rifaximin
- Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic EncephalopathyRecruitingPhase 3Tanta UniversityNCT04161053Written as Rifaximin
- Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without ConstipationWithdrawnPhase 1/2Sadat City UniversityNCT05453916Written as Rifaximin 550Mg Tab
- Clostridium Butyricum CBM588® vs. Rifaximin for Symptomatic Uncomplicated Diverticular Disease (SUDD): A Real-World Retrospective StudyCompletedNot applicableDr. Amjad KhanNCT06852274Written as Rifaximin 400 mg Oral Tablet
- Effect of a Probiotic Formula on Reducing SIBO in IBS PatientsTerminatedNot applicableAB Biotics, SANCT04316806Written as Rifaximin
- MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)CompletedPhase 2MallinckrodtNCT03712280Written as Rifaximin
- Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic EncephalopathyCompletedNot applicableBogomolets National Medical UniversityNCT04787276Written as Rifaximin
- High Volume Plasmapheresis for Refractory Hepatic Encephalopathy in Liver Intensive Care Unit.WithdrawnNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT03115697Written as Rifaximin
- The Effects of Nitazoxanide in Hepatic EncephalopathyStatus unknownPhase 2Ain Shams UniversityNCT02334163Written as Rifaximine
- Efficacy of Pentoxifylline and Rifaximin Combination in Pentoxifylline Refractory Clinical and Subclinical Hepatopulmonary SyndromeStatus unknownNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT01676597Written as pentoxifylline and rifaximin
- Bacterial Overgrowth Associated With Chronic Multisymptom Illness ComplexStatus unknownPhase 1Henry C. Lin, MDNCT00956150Written as Rifaximin
Codes
What other systems call Rifaximin · ClinicalTrials.gg INT006823
- MeSH (NLM) D000078262RifaximinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) L36O5T016NRIFAXIMINConfirmed FDA, NLM, Wikidata
- RxNorm 35619Confirmed FDA, Wikidata
- Wikidata Q416073rifaximinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61926RifaximinOne source FDA
- DrugBank DB01220One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000078262 | Rifaximin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | L36O5T016N | RIFAXIMIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 35619 | — | Confirmed FDA, Wikidata |
| Wikidata | Q416073 | rifaximin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61926 | Rifaximin | One source FDA |
| DrugBank | DB01220 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.